Sichuan Huiyu Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio
Sichuan Huiyu Pharmaceutical Co Ltd cash flow-to-debt ratio. Sichuan Huiyu Pharmaceutical Co Ltd (688553) has a Cash Flow-to-Debt Ratio of 0.05x as of September 2025, meaning its operating cash flow of CN¥58.54 Million could theoretically repay 0% of its total liabilities (CN¥1.16 Billion) in one year. Check Sichuan Huiyu Pharmaceutical Co Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Sichuan Huiyu Pharmaceutical Co Ltd (2017–2024)
Cash flow-to-debt ratio of Sichuan Huiyu Pharmaceutical Co Ltd from 2017 to 2024. Historical debt coverage capacity for Sichuan Huiyu Pharmaceutical Co Ltd across 8 annual periods. Check 688553 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Sichuan Huiyu Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio by Year (2017–2024)
Sichuan Huiyu Pharmaceutical Co Ltd cash flow-to-debt ratio by year from 2017 to 2024. Year-by-year debt coverage analysis for Sichuan Huiyu Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see 688553 cash flow metrics.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.20x | CN¥242.96 Million | CN¥1.19 Billion | ▲ +177.4% |
| 2023 | 0.07x | CN¥66.93 Million | CN¥911.22 Million | ▼ -78.9% |
| 2022 | 0.35x | CN¥194.06 Million | CN¥558.44 Million | ▼ -55.5% |
| 2021 | 0.78x | CN¥446.36 Million | CN¥571.01 Million | ▼ -7.1% |
| 2020 | 0.84x | CN¥387.95 Million | CN¥461.26 Million | ▲ +16.4% |
| 2019 | 0.72x | CN¥326.22 Million | CN¥451.33 Million | ▲ +174.4% |
| 2018 | 0.26x | CN¥129.06 Million | CN¥490.02 Million | ▲ +944.2% |
| 2017 | -0.03x | CN¥-13.16 Million | CN¥421.94 Million | — |